The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Reading a meta-analysis you disagree with, fairly

This is a generated summary. It shows the 5 most-liked posts from a topic of 14, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
SO
sa.okonkwoTL2 Moderator12 Jun 2024#1

Posting this under the heading it deserves: Reading a meta-analysis you disagree with, fairly Everything below is what sits behind that.

I have seen SURPASS-2 (N Engl J Med, 2021) cited in support of a claim I do not think it supports, twice this month, so I would like to work through what it actually shows.

My reading is that the trial is sound for its own question and is being stretched to answer a different one. I might be wrong about that, which is why this is a topic rather than a correction.

What I would like from this discussion: someone who disagrees with me to say why, with the section of the paper they are relying on.

37 likes 2.1y
LA
l.aaltonenTL3Regular7 Jul 2024#4
p.onwuka, post #3: Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are too narrow, the meta-analysis answers a overly specific question. Go to post

Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes studies are estimating effects from different distributions and allows between-study variance. Choice matters if heterogeneity is high.

8 likes in reply to #3 2.1y
SD
s.demirTL2 Moderator14 Jul 2024 · edited#5
sa.okonkwo, post #1: Posting this under the heading it deserves: Reading a meta-analysis you disagree with, fairly Everything below is what sits behind that. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in support of a claim I do not think it supports, twice this month, so I would like to work through what it actually shows. My reading is that the… Go to post

Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High heterogeneity means effects genuinely differ across studies. The pooled number is an average of things that should not have been averaged.

27 likes in reply to #1 2y
N
NLoughranTL3Regular31 Jul 2024#8
vial_slope, post #6: When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents nothing in particular. Reading the individual studies is more useful than reading the pooled estimate. Go to post

Coming back to post #6, because the follow-up matters more than the original answer.

Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest plot with only large studies on the positive end is a red flag for unpublished small negative studies.

13 likes in reply to #6 2y
SM
so.mbekiTL2 Moderator21 Aug 2024#12
l.aaltonen, post #4: Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes studies are estimating effects from different distributions and allows between-study variance. Choice matters if heterogeneity is high. Go to post

Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be cautious — many subgroup analyses are exploratory and less reliable than the main analysis.

29 likes in reply to #4 23mo

Read the full topic (14 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Publication bias detection and its low power
On the subject in the title: Publication bias detection and its low power Working notes rather than a conclusion. I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a claim I do not think it…
MAZLKK 2 3.2k 1d
Second pass at: A pooled estimate that changed when one trial was added
On the subject in the title: Second pass at: A pooled estimate that changed when one trial was added Working notes rather than a conclusion. Session topic: SELECT ( N Engl J Med , 2023). Please read it before…
FLSTYAWNRM+26 30 22k 1mo
Heterogeneity as information rather than as a nuisance
Posting this under the heading it deserves: Heterogeneity as information rather than as a nuisance Everything below is what sits behind that. Session topic: SCALE ( N Engl J Med , 2015). Please read it before…
DFRJMNAN+88 95 1.2k 6mo
Random versus fixed effects: choosing rather than defaulting
Random versus fixed effects: choosing rather than defaulting — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med , 2024). Please read it before posting;…
NPFSMLAJS+16 20 22k 13mo
Risk-of-bias tools and the judgement they conceal — does this still hold?
Risk-of-bias tools and the judgement they conceal — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
GLGEBSR+26 30 5.8k 23h

Related topics — sharing the tags heterogeneity, risk of bias, effect size

TopicParticipantsRepliesViewsActivity
Follow-up: Individual participant data versus aggregate data
Individual participant data versus aggregate data — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURPASS-4 ( Lancet , 2021) and finding the…
HDAPRSGVRV+101 111 23k 18mo
Second pass at: A pooled estimate that changed when one trial was added
On the subject in the title: Second pass at: A pooled estimate that changed when one trial was added Working notes rather than a conclusion. Session topic: SELECT ( N Engl J Med , 2023). Please read it before…
FLSTYAWNRM+26 30 22k 1mo
Journal club: semaglutide in MASH, and surrogate endpoints
Posting this under the heading it deserves: Journal club: semaglutide in MASH, and surrogate endpoints Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with SURMOUNT-2 (…
MDSRSGSLSC+24 28 17k 15h
Sample size intuition for a personal experiment — does this still hold?
Sample size intuition for a personal experiment — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing STEP 1 ( N Engl J Med , 2021) with…
AWMSNVBIFA+33 38 26k 23d
How this community labels and discusses unrefereed work — the long version
Asking directly, because I could not find a straight answer: How this community labels and discusses unrefereed work — the long version I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a…
ITLCNBBI+18 23 21k 2mo